RxDoctor Payments Data

Arthur Browning, MD

Family Medicine · Jacksonville, FLNPI 1366429904

Payments from drug & device makers

$5,378in general payments, 2019–2025

Across 349 payments — averaging $15.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$689
  • Novo Nordisk$409
  • Amgen$399
  • Boehringer Ingelheim$353
  • Lilly USA, LLC$294
  • GSK$269
  • plus $3K from 45 others

What the payments were for

  • Food & beverage$5,378100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,378 in reported general payments places this provider in the 85th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$41,202
Medicare patients
95
Services billed
316

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban113$55,607
OzempicSemaglutide28$35,215
MounjaroTirzepatide13$14,493
FarxigaDapagliflozin Propanediol14$14,429
Trelegy ElliptaFluticasone/Umeclidin/Vilanter19$13,298
JardianceEmpagliflozin12$11,107
Soliqua 100-33Insulin Glargine/Lixisenatide13$10,840
EdarbyclorAzilsartan Med/Chlorthalidone12$3,496
SynthroidLevothyroxine Sodium18$2,392
Atorvastatin Calcium173$1,463
Flecainide Acetate12$1,402
Citalopram HbrCitalopram Hydrobromide87$1,393
PaxlovidNirmatrelvir/Ritonavir16$1,368
Potassium Chloride95$1,160
Levetiracetam64$1,092

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Paxlovid$174$56,975129 claims
Novo NordiskOzempic$409$35,21528 claims
Lilly USA, LLCMounjaro$294$14,49313 claims
AstraZenecaFarxiga$206$14,42914 claims
GSKTrelegy Ellipta$269$13,29819 claims
Boehringer IngelheimJardiance$353$11,10712 claims
Sanofi-aventis U.S. LLCSoliqua 100-33$174$10,84013 claims
Arbor Pharmaceuticals, Inc.Edarbyclor$75$3,49612 claims
AbbVieSynthroid$689$2,39218 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Jacksonville

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →